Close Menu

NEW YORK (GenomeWeb News) – Monsanto has acquired agricultural biotechnology firm GrassRoots Biotechnology for an undisclosed amount.

The acquisition was made earlier this month, and in an e-mail to GenomeWeb Daily News, a Monsanto spokesperson said, "GrassRoots focuses on gene expression and other agricultural technologies that will complement Monsanto's biotechnology research and development work."

All research employees will be offered positions at Monsanto. The spokesperson declined to disclose further terms of the deal.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.